Multi-drug Resistant Tuberculosis: Clinical Trials

1 trial for Multi-drug Resistant Tuberculosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Completed 1

Follow Multi-drug Resistant Tuberculosis: new trials by email Literature Review of Multi-drug Resistant Tuberculosis trials Research Report on Multi-drug Resistant Tuberculosis

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Effect of 18-month Regimen Containing 6 Anti-tuberculosis Drugs for Patients With MDR-TB
18-month regimen containing 6 anti-TB drugs - Multi-drug Resistant Tuberculosis
Phase 4CompletedBeijing Chest Hospital5152019-03-082022-10-12

Narrower conditions

Tuberculosis, Multidrug-Resistant (1)

Broader conditions

Actinomycetales Infections (1)  ·  Bacterial Infections (1)  ·  Bacterial Infections and Mycoses (1)  ·  Gram-Positive Bacterial Infections (1)  ·  Infections (1)  ·  Mycobacterium Infections (1)  ·  Tuberculosis (1)

Sponsors

Beijing Chest Hospital (1)

Countries

China (1)